These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 3302708

  • 21. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial.
    Ribera JM, Oriol A, Bethencourt C, Parody R, Hernández-Rivas JM, Moreno MJ, del Potro E, Torm M, Rivas C, Besalduch J, Sanz MA, Ortega JJ, PETHEMA Group, Spain.
    Haematologica; 2005 Oct; 90(10):1346-56. PubMed ID: 16219571
    [Abstract] [Full Text] [Related]

  • 22. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
    Socié G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C, Cahn JY, Passweg JR, Rowlings PA, Schouten HC, Kolb HJ, Klein JP.
    N Engl J Med; 1999 Jul 01; 341(1):14-21. PubMed ID: 10387937
    [Abstract] [Full Text] [Related]

  • 23. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
    Kiehl MG, Kraut L, Schwerdtfeger R, Hertenstein B, Remberger M, Kroeger N, Stelljes M, Bornhaeuser M, Martin H, Scheid C, Ganser A, Zander AR, Kienast J, Ehninger G, Hoelzer D, Diehl V, Fauser AA, Ringden O.
    J Clin Oncol; 2004 Jul 15; 22(14):2816-25. PubMed ID: 15254049
    [Abstract] [Full Text] [Related]

  • 24. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S, Cho BS, Kim SY, Choi SM, Lee DG, Eom KS, Kim YJ, Kim HJ, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Shin WS, Kim CC.
    Biol Blood Marrow Transplant; 2007 Sep 15; 13(9):1083-94. PubMed ID: 17697971
    [Abstract] [Full Text] [Related]

  • 25. Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse.
    Soiffer RJ, Roy DC, Gonin R, Murray C, Anderson KC, Freedman AS, Rabinowe SN, Robertson MJ, Spector N, Pesek K.
    Bone Marrow Transplant; 1993 Sep 15; 12(3):243-51. PubMed ID: 8241984
    [Abstract] [Full Text] [Related]

  • 26. Allogeneic bone marrow transplantation.
    Weiden PL.
    Crit Rev Clin Lab Sci; 1983 Sep 15; 19(3):173-86. PubMed ID: 6373140
    [Abstract] [Full Text] [Related]

  • 27. Bone marrow transplantation for chronic myelogenous leukemia: clinical outcomes.
    Enright H, Davies S, McGlave P.
    Clin Transpl; 1994 Sep 15; ():283-93. PubMed ID: 7547549
    [Abstract] [Full Text] [Related]

  • 28. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission.
    Lee SH, Lee MH, Lee JH, Min YH, Lee KH, Cheong JW, Lee J, Park KW, Kang JH, Kim K, Kim WS, Jung CW, Choi SJ, Lee JH, Park K.
    Biol Blood Marrow Transplant; 2005 Feb 15; 11(2):122-8. PubMed ID: 15682073
    [Abstract] [Full Text] [Related]

  • 29. Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma.
    Verdonck LF, van Putten WL, Hagenbeek A, Schouten HC, Sonneveld P, van Imhoff GW, Kluin-Nelemans HC, Raemaekers JM, van Oers RH, Haak HL.
    N Engl J Med; 1995 Apr 20; 332(16):1045-51. PubMed ID: 7898521
    [Abstract] [Full Text] [Related]

  • 30. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
    Uderzo C, Dini G, Locatelli F, Miniero R, Tamaro P.
    Haematologica; 2000 Nov 20; 85(11 Suppl):47-53. PubMed ID: 11268324
    [Abstract] [Full Text] [Related]

  • 31. Long-term results in non randomized patients with acute myelogenous leukemia: a single institution experience.
    Deliliers GL, Annaloro C, Oriani A, Della Volpe A, Boschetti C, Cortelezzi A, Maiolo AT.
    Ann Ital Med Int; 1998 Nov 20; 13(3):146-51. PubMed ID: 9859570
    [Abstract] [Full Text] [Related]

  • 32. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N, Bornhäuser M, Ehninger G, Schwerdtfeger R, Biersack H, Sayer HG, Wandt H, Schäfer-Eckardt K, Beyer J, Kiehl M, Zander AR, German Cooperative Transplant Study Group.
    Ann Hematol; 2003 Jun 20; 82(6):336-42. PubMed ID: 12728337
    [Abstract] [Full Text] [Related]

  • 33. Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia.
    Blume KG, Beutler E, Bross KJ, Chillar RK, Ellington OB, Fahey JL, Farbstein MJ, Forman SJ, Schmidt GM, Scott EP, Spruce WE, Turner MA, Wolf JL.
    N Engl J Med; 1980 May 08; 302(19):1041-6. PubMed ID: 6245359
    [Abstract] [Full Text] [Related]

  • 34. Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia.
    Uckun FM, Kersey JH, Haake R, Weisdorf D, Nesbit ME, Ramsay NK.
    N Engl J Med; 1993 Oct 28; 329(18):1296-301. PubMed ID: 8413410
    [Abstract] [Full Text] [Related]

  • 35. Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies.
    Champlin R, Gale RP.
    Semin Hematol; 1987 Jan 28; 24(1):55-67. PubMed ID: 3547673
    [Abstract] [Full Text] [Related]

  • 36. Reasons that patients with acute myelogenous leukemia do not undergo allogeneic bone marrow transplantation.
    Berman E, Little C, Gee T, O'Reilly R, Clarkson B.
    N Engl J Med; 1992 Jan 16; 326(3):156-60. PubMed ID: 1727546
    [Abstract] [Full Text] [Related]

  • 37. Marrow transplantation for patients with acute lymphoblastic leukemia in first marrow remission.
    Doney K, Buckner CD, Kopecky KJ, Sanders JE, Appelbaum FR, Clift R, Sullivan K, Witherspoon R, Storb R, Thomas ED.
    Bone Marrow Transplant; 1987 Dec 16; 2(4):355-63. PubMed ID: 3332183
    [Abstract] [Full Text] [Related]

  • 38. Detection of residual acute lymphoblastic leukemia cells in cultures of bone marrow obtained during remission.
    Estrov Z, Grunberger T, Dubé ID, Wang YP, Freedman MH.
    N Engl J Med; 1986 Aug 28; 315(9):538-42. PubMed ID: 3488505
    [Abstract] [Full Text] [Related]

  • 39. Unrelated donor or autologous marrow transplantation for treatment of acute leukemia.
    Busca A, Anasetti C, Anderson G, Appelbaum FR, Buckner CD, Doney K, Martin PJ, Petersdorf E, Sanders JE, Hansen JA.
    Blood; 1994 May 15; 83(10):3077-84. PubMed ID: 8180404
    [Abstract] [Full Text] [Related]

  • 40. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission.
    Blume KG, Forman SJ, Snyder DS, Nademanee AP, O'Donnell MR, Fahey JL, Krance RA, Sniecinski IJ, Stock AD, Findley DO.
    Transplantation; 1987 Mar 15; 43(3):389-92. PubMed ID: 3547796
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.